BIOMAT Database Logo BIOMAT Database Logo

Correlation between daily fluctuations of carbamazepine serum levels and intermittent side effects. 1980

R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002220 Carbamazepine A dibenzazepine that acts as a sodium channel blocker. It is used as an anticonvulsant for the treatment of grand mal and psychomotor or focal SEIZURES. It may also be used in the management of BIPOLAR DISORDER, and has analgesic properties. Amizepine,Carbamazepine Acetate,Carbamazepine Anhydrous,Carbamazepine Dihydrate,Carbamazepine Hydrochloride,Carbamazepine L-Tartrate (4:1),Carbamazepine Phosphate,Carbamazepine Sulfate (2:1),Carbazepin,Epitol,Finlepsin,Neurotol,Tegretol
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D004827 Epilepsy A disorder characterized by recurrent episodes of paroxysmal brain dysfunction due to a sudden, disorderly, and excessive neuronal discharge. Epilepsy classification systems are generally based upon: (1) clinical features of the seizure episodes (e.g., motor seizure), (2) etiology (e.g., post-traumatic), (3) anatomic site of seizure origin (e.g., frontal lobe seizure), (4) tendency to spread to other structures in the brain, and (5) temporal patterns (e.g., nocturnal epilepsy). (From Adams et al., Principles of Neurology, 6th ed, p313) Aura,Awakening Epilepsy,Seizure Disorder,Epilepsy, Cryptogenic,Auras,Cryptogenic Epilepsies,Cryptogenic Epilepsy,Epilepsies,Epilepsies, Cryptogenic,Epilepsy, Awakening,Seizure Disorders
D006207 Half-Life The time it takes for a substance (drug, radioactive nuclide, or other) to lose half of its pharmacologic, physiologic, or radiologic activity. Halflife,Half Life,Half-Lifes,Halflifes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000927 Anticonvulsants Drugs used to prevent SEIZURES or reduce their severity. Anticonvulsant,Anticonvulsant Drug,Anticonvulsive Agent,Anticonvulsive Drug,Antiepileptic,Antiepileptic Agent,Antiepileptic Agents,Antiepileptic Drug,Anticonvulsant Drugs,Anticonvulsive Agents,Anticonvulsive Drugs,Antiepileptic Drugs,Antiepileptics,Agent, Anticonvulsive,Agent, Antiepileptic,Agents, Anticonvulsive,Agents, Antiepileptic,Drug, Anticonvulsant,Drug, Anticonvulsive,Drug, Antiepileptic,Drugs, Anticonvulsant,Drugs, Anticonvulsive,Drugs, Antiepileptic
D013997 Time Factors Elements of limited time intervals, contributing to particular results or situations. Time Series,Factor, Time,Time Factor

Related Publications

R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Diurnal fluctuations in free and total steady-state plasma levels of carbamazepine and correlation with intermittent side effects.
August 1984, Epilepsia,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Interdosage fluctuations in plasma carbamazepine concentration determine intermittent side effects.
August 1984, Archives of neurology,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Serum carbamazepine concentration--dose dependency and daily fluctuations.
January 1980, Folia psychiatrica et neurologica japonica,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Daily fluctuation of plasma levels with conventional and controlled-release carbamazepine: correlation with adverse effects.
January 1994, International clinical psychopharmacology,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Adverse effects from the circadian fluctuations of carbamazepine plasma levels.
May 1983, Acta paediatrica Scandinavica,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Correlation between Serum Level of Antiepileptic Drugs and their Side Effects.
January 2010, Oman medical journal,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Correlation between plasma carbamazepine-10,11-epoxide concentration and drug side-effects in children with epilepsy.
December 1984, Developmental medicine and child neurology,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Correlation between the total cholesterol serum concentration data and carbamazepine steady-state blood levels in humans.
November 1983, Drug intelligence & clinical pharmacy,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
Free and total plasma concentrations of carbamazepine and carbamazepine-10,11-epoxide in epileptic patients: diurnal fluctuations and relationship with side effects.
January 1984, Therapeutic drug monitoring,
R J Höppener, and A Kuyer, and J W Meijer, and J Hulsman
The side-effects of carbamazepine.
June 1969, Proceedings of the Royal Society of Medicine,
Copied contents to your clipboard!